Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03477864
Title Stereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants With Progressive Advanced or Oligometastatic Prostate Cancer
Recruitment Withdrawn
Gender male
Phase Phase I
Variant Requirements No
Sponsors Sidney Kimmel Cancer Center at Thomas Jefferson University
Indications

prostate cancer

Therapies

Ipilimumab

Cemiplimab + Ipilimumab

Cemiplimab

Age Groups: senior | adult
Covered Countries


No variant requirements are available.